A Meta-Analysis of Interleukin-10 -592 Promoter Polymorphism Associated with Gastric Cancer Risk
暂无分享,去创建一个
Ying-chao Wang | Huiping Xue | B. Lin | Jin-xian Chen | Lu Chen | J. Fang | Jian-fu An
[1] Bin Liu,et al. : Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and , 2010 .
[2] Gang Huang,et al. Interleukin-10-819 promoter polymorphism in association with gastric cancer risk , 2012, BMC Cancer.
[3] R. Zhou,et al. −251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case–control studies , 2012, Molecular Biology Reports.
[4] Xianze Meng,et al. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells , 2012, Medical Oncology.
[5] Z. Wang,et al. A Meta-Analysis of Interleukin-8 -251 Promoter Polymorphism Associated with Gastric Cancer Risk , 2012, PloS one.
[6] Yun Cui,et al. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. , 2011, DNA and cell biology.
[7] G. Launoy,et al. Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010 , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[8] V. Valenti,et al. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy , 2011, Journal of surgical oncology.
[9] H. Lenz,et al. Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models , 2011, International journal of cancer.
[10] B. Song,et al. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. , 2011, World journal of gastroenterology.
[11] Jing Wang,et al. The association between interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis , 2011, Medical oncology.
[12] Peihua Ni,et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. , 2011, American journal of epidemiology.
[13] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[14] Gang Huang,et al. Interleukin‐1B and interleukin‐1 RN polymorphisms and gastric carcinoma risk: A meta‐analysis , 2010, Journal of gastroenterology and hepatology.
[15] Bin Liu,et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.
[16] H. Jung,et al. The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. , 2010, Cytokine.
[17] N. Hu,et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.
[18] Jing Wang,et al. Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis , 2010, Digestive Diseases and Sciences.
[19] Liu Liu,et al. Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. , 2010, Cytokine.
[20] Tai-xiang Wu,et al. Interleukin10 -592 Promoter Polymorphism Associated with Gastric Cancer Among Asians: A Meta-Analysis of Epidemiologic Studies , 2010, Digestive Diseases and Sciences.
[21] Weibo Liang,et al. IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. , 2010, European journal of cancer.
[22] Weiwei Niu,et al. Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China , 2010, Molecular Biology Reports.
[23] C. Peng,et al. Interleukin-10-819 Promoter Polymorphism Associated with Gastric Cancer among Asians , 2010, The Journal of international medical research.
[24] L. Xiaobo,et al. Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[25] Shu-Chen Wang,et al. Association of Interleukin-8 with Cachexia from Patients with Low-Third Gastric Cancer , 2009, Comparative and functional genomics.
[26] B. Xia,et al. [Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population]. , 2009, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[27] D. Kang,et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. , 2009, The Journal of nutrition.
[28] Nayoung Kim,et al. The Effects of Genetic Polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced Gastroduodenal Diseases in Korea , 2009, Journal of clinical gastroenterology.
[29] J. S. Kim,et al. The Interleukin-8–251 A Allele is Associated With Increased Risk of Noncardia Gastric Adenocarcinoma in Helicobacter pylori-infected Koreans , 2009, Journal of clinical gastroenterology.
[30] Sushovan Guha,et al. CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer , 2009 .
[31] N. Yasuda,et al. Role of bacterial and genetic factors in gastric cancer in Costa Rica. , 2009, World journal of gastroenterology.
[32] D. Fan,et al. Molecular basis of therapeutic approaches to gastric cancer , 2009, Journal of gastroenterology and hepatology.
[33] F. Clavel-Chapelon,et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] Tai-xiang Wu,et al. Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians. , 2008, European journal of cancer.
[35] J. Thompson,et al. How should we use information about HWE in the meta-analyses of genetic association studies? , 2008, International journal of epidemiology.
[36] F. Canzian,et al. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[37] Á. Lanas,et al. Gastric Cancer Susceptibility Is Not Linked to Pro-and Anti-Inflammatory Cytokine Gene Polymorphisms in Whites: A Nationwide Multicenter Study in Spain , 2007, The American Journal of Gastroenterology.
[38] H. Sugimura,et al. Effects of interleukin‐10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects , 2007, Journal of gastroenterology and hepatology.
[39] Jing Shen,et al. [Meta-analysis on the relationship between IL8-251 gene polymorphism and gastric cancer]. , 2007, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[40] G. Perez-Perez,et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer , 2007, BMC Cancer.
[41] S. Tsujitani,et al. Distinct Recurrence Pattern and Outcome of Adenocarcinoma of the Gastric Cardia in Comparison with Carcinoma of Other Regions of the Stomach , 2006, World Journal of Surgery.
[42] Christopher F. Martin,et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[43] E. Fontham,et al. Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.
[44] K. Lankarani,et al. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. , 2006, World journal of gastroenterology.
[45] H. Yatsuya,et al. Interleukin‐8 gene polymorphism associated with susceptibility to non‐cardia gastric carcinoma with microsatellite instability , 2006, Journal of gastroenterology and hepatology.
[46] L. Hou,et al. Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population , 2006, Cancer Epidemiology Biomarkers & Prevention.
[47] R. R. Henry,et al. Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin‐1 and ‐10 genes , 2006, International journal of cancer.
[48] A. Hutchinson,et al. Polymorphisms in Inflammation-related Genes and Risk of Gastric Cancer (Finland) , 2006, Cancer Causes & Control.
[49] Ling Yang,et al. Incidence and mortality of gastric cancer in China. , 2006, World journal of gastroenterology.
[50] G. Perez-Perez,et al. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica , 2005, Clinical and Experimental Medicine.
[51] Y. Hirooka,et al. Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan , 2005, Cancer Epidemiology Biomarkers & Prevention.
[52] F. Marincola,et al. Interleukin‐10 and the immune response against cancer: a counterpoint , 2005, Journal of leukocyte biology.
[53] Yi-ping Lin,et al. The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population , 2005, Clinical Cancer Research.
[54] Ammarin Thakkinstian,et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.
[55] Joon-Yong Park,et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. , 2005, Cancer letters.
[56] Ammarin Thakkinstian,et al. A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.
[57] H. Lee,et al. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach , 2005, Cancer.
[58] E. El-Omar,et al. Role of the polymorphic IL‐1B, IL‐1RN and TNF‐A genes in distal gastric cancer in Mexico , 2005, International journal of cancer.
[59] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[60] D. Lin,et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. , 2005, Carcinogenesis.
[61] M. Rugge,et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. , 2005, Cytokine.
[62] W. Guo,et al. Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. , 2005, World journal of gastroenterology.
[63] T. Koike,et al. The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.
[64] S. Chanock,et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[65] S. Chanock,et al. Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[66] Chien-Jen Chen,et al. Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.
[67] J. Goedert,et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.
[68] Leif E. Peterson,et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .
[69] Yasuo Suzuki,et al. Suppression of Helicobacter pylori‐induced interleukin‐8 production in gastric cancer cell lines by an anti‐ulcer drug, geranylgeranylacetone , 2002, Journal of gastroenterology and hepatology.
[70] R. Eeles,et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. , 2002, Cancer research.
[71] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[72] K. Chayama,et al. Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? , 2001, European journal of cancer.
[73] D. Kwiatkowski,et al. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.
[74] G. Catalano,et al. Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies , 1999, Cancer.
[75] I. Fidler,et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice , 1999, British Journal of Cancer.
[76] H. Wanebo,et al. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck , 1997, Annals of Surgical Oncology.
[77] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[78] A. Ben-Baruch,et al. Signals and Receptors Involved in Recruitment of Inflammatory Cells (*) , 1995, The Journal of Biological Chemistry.
[79] R. Rappuoli,et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. , 1995, Journal of clinical pathology.
[80] D. Taub,et al. Chemokines, inflammation and the immune system. , 1994, Therapeutic immunology.
[81] C. O'Morain,et al. Helicobacter pylori Infection , 1994 .
[82] D. Dinsdale,et al. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. , 1985, Carcinogenesis.
[83] A. Jemal,et al. Global Cancer Statistics , 2011 .
[84] Xiaoting Wu,et al. Interleukin-10 −1082 promoter polymorphism and gastric cancer risk in a Chinese Han population , 2010, Molecular and Cellular Biochemistry.
[85] Peng Xiaowei. The relationship among IL-10 gene polymorphisms,Helicobacter pylori and noncardia gastric cancer development in Fujian province , 2008 .
[86] E. Fontham,et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. , 2006, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[87] Hu Pin-jin. Correlation of Polymorphism of Interleukin 8 Gene-251 Locus and Gastric Cancer in High and Low Prevalence Regions in China , 2005 .
[88] W. Mellin,et al. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.
[89] Leif E. Peterson,et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. , 2002, Gastroenterology.
[90] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[91] P. Subramaniam,et al. Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. , 1999, Blood.
[92] P. Subramaniam,et al. Mechanism of Interleukin-10 Inhibition of T-Helper Cell Activation by Superantigen at the Level of the Cell Cycle , 1999 .